Page 373 - Biomedical Engineering and Design Handbook Volume 1, Fundamentals
P. 373

350  BIOMATERIALS


























                                       A                                     B
                       FIGURE 14.5  Surface traces of indentation cracks in alumina-glass dental composite by backscattered scanning
                       electron microscopy (SEM). Grain bridging sites are near the arrows in (a) and transgranular fracture sites in (b). (From
                       Ref. 21.)



                       bone cements, although this is a very slow phenomenon. Visocelastic effects such as the strain-rate
                       dependence of stiffness and long-term creep are proportional to the column fraction of matrix such
                       that highly reinforced continuous-fiber composites are less prone than short-fiber composites.



           14.7 BIOLOGIC RESPONSE

                       In designing biomedical composites and predicting their performance, several issues must be
                       considered regarding the biological response. As the number of constituent materials in a composite
                       increases, so can the variations in the host response. Additional tests are necessary to establish that
                       while the individual materials may be by themselves biocompatible, their specific composition,
                       arrangement, and interaction are also biocompatible. This has implications for both the flexibility of
                       design and obtaining regulatory approval. The potential of composite design to obtain the desired set
                       of properties can be restricted by being conservative in the choice and number of materials used.
                       Even if all the materials used may be approved by the Food and Drug Administration (FDA), their
                       particular combination in a composite may require additional approval.
                         Materials can elicit a different host response in the bulk form than in the fibrous or particulate
                       form. For instance, UHMWPE, as in an acetabular cup of a hip prosthesis, is generally biocompatible,
                       whereas its fibrous form, as in a finely woven fabric, has been shown to produce a different, more
                       adverse reaction. Furthermore, when the discontinuous phase is particles, whiskers, platelets, or
                       microspheres with dimensions on a cellular scale, the inflammatory response can include their
                       ingestion by immune cells and transport to other parts of the body. This can be accompanied by the
                       release of enzymes that can adversely affect the performance of the composite, such as by altering
                                                               7
                       the degradation kinetics of a biodegradable composite. The composite can be designed in such a
                       way that the fibers or particles are not exposed to the host, but this is challenging because it involves
                       elimination of all voids at the fiber-matrix or particle-matrix interface during processing. In addition,
   368   369   370   371   372   373   374   375   376   377   378